Many ASCs were anticipating growth and prosperity in 2020 — until COVID-19 struck. 

Before the pandemic, ASCs were projecting 6 to 7 percent growth driven by lower surgical costs, changes in reimbursement rules and greater convenience for patients. Many of these factors haven't changed, but new challenges regarding supply management and vendor partnerships have arisen.

Fortunately, ASCs are known for agility, allowing for administrators to creatively manage through the COVID-19 pandemic. 

This report, based on industry experts' insights, explains why:

• The preference for surgery centers is likely to persist beyond the pandemic.
• Materials managers are playing a more important role than ever.
• Vendor relationships based on long-term strategic goals are beneficial.